InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

- Current share price for PIQ : $0.125

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$21 Final Director's Interest Notice 23 Feb 2026 4:32PM $0.365 $0.125 fallen by 65.75%
$21 Resignation of Joint Company Secretary 5 Feb 2026 9:11AM $0.490 $0.125 fallen by 74.49%
$21 Application for quotation of securities - PIQ 2 Feb 2026 10:42AM $0.520 $0.125 fallen by 75.96%
$21 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2026 8:25AM $0.570 $0.125 fallen by 78.07%
$21 Application for quotation of securities - PIQ 21 Jan 2026 3:30PM $0.720 $0.125 fallen by 82.64%
$21 Initial Director's Interest Notice 19 Jan 2026 10:05AM $0.815 $0.125 fallen by 84.66%
$21 Canadian patent secured for PromarkerEso test for EAC 16 Jan 2026 8:22AM $0.775 $0.125 fallen by 83.87%
$21 Application for quotation of securities - PIQ 16 Jan 2026 8:20AM $0.775 $0.125 fallen by 83.87%
$21 Appointment of CEO and Managing Director 14 Jan 2026 8:44AM $0.790 $0.125 fallen by 84.18%
$21 Application for quotation of securities - PIQ 12 Jan 2026 10:23AM $0.665 $0.125 fallen by 81.20%
$21 Notification of cessation of securities - PIQ 9 Jan 2026 11:08AM $0.685 $0.125 fallen by 81.75%
$21 Proteomics US lab CAP accredited - extends precision Dx lab 24 Dec 2025 10:15AM $0.525 $0.125 fallen by 76.19%
$21 Application for quotation of securities - PIQ 22 Dec 2025 8:38AM $0.510 $0.125 fallen by 75.49%
$21 US patent secured for PromarkerEso diagnostic test for EAC 17 Dec 2025 8:33AM $0.530 $0.125 fallen by 76.42%
$21 PromarkerD changes how Doctors manage DKD - study published 16 Dec 2025 8:45AM $0.480 $0.125 fallen by 73.96%
$21 PromarkerD predicts risk of DKD in Aboriginal Australians 15 Dec 2025 8:21AM $0.490 $0.125 fallen by 74.49%
$21 Investor presentation - TSN ASX Gems Conference 12 Dec 2025 9:59AM $0.460 $0.125 fallen by 72.83%
$21 Response to ASX Price Query 2 Dec 2025 3:52PM $0.470 $0.125 fallen by 73.40%
$21 US Medicare sets reimbursement price for PromarkerD DKD test 26 Nov 2025 9:58AM $0.335 $0.125 fallen by 62.69%
$21 Application for quotation of securities - PIQ 26 Nov 2025 9:29AM $0.335 $0.125 fallen by 62.69%
$21 Notification regarding unquoted securities - PIQ 26 Nov 2025 9:27AM $0.335 $0.125 fallen by 62.69%
$21 Change of Director's Interest Notice x3 26 Nov 2025 8:32AM $0.335 $0.125 fallen by 62.69%
$21 Notification of cessation of securities - PIQ 26 Nov 2025 8:29AM $0.335 $0.125 fallen by 62.69%
$21 OxiDx test correlates with superior racehorse performance 24 Nov 2025 8:37AM $0.325 $0.125 fallen by 61.54%
$21 Results of Meeting 21 Nov 2025 2:46PM $0.320 $0.125 fallen by 60.94%

26 - 50 of 698 results

Page 2 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.